PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.91%
Negative revenue growth while 2127.T stands at 26.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.58%
Gross profit growth under 50% of 2127.T's 33.41%. Michael Burry would be concerned about a severe competitive disadvantage.
0.43%
EBIT growth below 50% of 2127.T's 40.73%. Michael Burry would suspect deeper competitive or cost structure issues.
-2.15%
Negative operating income growth while 2127.T is at 41.09%. Joel Greenblatt would press for urgent turnaround measures.
-2.62%
Negative net income growth while 2127.T stands at 35.24%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.63%
Negative EPS growth while 2127.T is at 35.56%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.63%
Negative diluted EPS growth while 2127.T is at 37.87%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.03%
10Y revenue/share CAGR under 50% of 2127.T's 135.77%. Michael Burry would suspect a lasting competitive disadvantage.
-4.03%
Negative 5Y CAGR while 2127.T stands at 251.69%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-25.88%
Negative 3Y CAGR while 2127.T stands at 68.61%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
90.97%
Below 50% of 2127.T's 235.90%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
0.73%
Below 50% of 2127.T's 595.76%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-24.36%
Negative 3Y CAGR while 2127.T is 76.45%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
63.24%
Equity/share CAGR of 63.24% while 2127.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
No Data
No Data available this quarter, please select a different quarter.
-10.18%
Negative 3Y equity/share growth while 2127.T is at 86.90%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.78%
Below 50% of 2127.T's 174.28%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
5.88%
AR growth of 5.88% while 2127.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
7.68%
Inventory shrinking or stable vs. 2127.T's 28.87%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.22%
Negative asset growth while 2127.T invests at 13.56%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.68%
Under 50% of 2127.T's 9.43%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-9.08%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.39%
SG&A declining or stable vs. 2127.T's 12.27%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.